Ralaniten
Clinical data | |
---|---|
Other names | EPI-002 |
Drug class | Nonsteroidal antiandrogen |
Identifiers | |
| |
JSmol) | |
| |
|
Ralaniten (developmental code name EPI-002) is an
stereoisomers of EPI-001.[1] A prodrug of ralaniten, ralaniten acetate (EPI-506), was under development for the treatment of prostate cancer.[3]